Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
The Battery ShowThe Battery Show
Not Confirmed
Not Confirmed
06-09 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
The Battery ShowThe Battery Show
Industry Trade Show
Not Confirmed
06-09 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
18 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/18/3152274/0/en/BioXcel-Therapeutics-Regains-Compliance-with-Nasdaq-Market-Value-of-Listed-Securities-Requirements.html
10 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/10/3147596/0/en/BioXcel-Therapeutics-Reports-Positive-Topline-Exploratory-Efficacy-Data-from-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Agitation-Associated-with-Bipolar-Disorders-or-Schizo.html
04 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/04/3144339/0/en/BioXcel-Therapeutics-to-Present-at-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html
26 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/26/3139590/0/en/BioXcel-Therapeutics-To-Announce-Topline-Results-from-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Acute-Treatment-of-Agitation-Associated-with-Bipolar-Disorders-or-Schizophre.html
19 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/19/3135577/0/en/BioXcel-Therapeutics-Announces-Database-Lock-in-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Acute-Treatment-of-Agitation-Associated-with-Bipolar-Disorders-or-Schizophrenia.html
18 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/18/3134889/0/en/BioXcel-Therapeutics-Announces-Positive-FDA-Pre-sNDA-Meeting-Comments-for-sNDA-Submission-for-BXCL501-in-Agitation-Associated-with-Bipolar-Disorders-or-Schizophrenia.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE